Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MEDICAMEQ | NSE
-10.05
-3.93%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/06/2026
245.65
256.95
261.60
243.35
Medicamen Biotech Limited researches develops manufactures sells and distributes pharmaceutical formulations and APIs in India. It offers a range of products including tablets such as non-beta lactum tablets; capsules comprising beta and non-beta lactum capsules; liquid and dry syrups; and ointments and creams. The company also provides lyohilized/dry powder injections and oral solid and liquid products. Its products are used in various therapeutic areas such as gastrointestinal pain management anti-infectives pediatrics dermatology gynecology and rheumatology diabetology cardiology oncology and the central nervous system. The company was incorporated in 1993 and is based in New Delhi India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
45.6%1 month
40.9%3 months
47.2%6 months
45.7%82.74
-
3.26
0.15
0.10
28.30
3.88
-
188.65M
3.03B
31.90M
0.19
3.89
-79.80
2.60
4.82
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
57.45
Range1M
57.45
Range3M
92.05
Rel. volume
1.97
Price X volume
11.46M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 173.7 | 2.81B | -2.33% | 42.44 | 17.95% |
| Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 11.98 | 2.71B | 0.00% | 138.07 | 59.44% |
| Lyka Labs Limited | LYKALABS | Biotechnology | 63.57 | 2.27B | 5.32% | 813.94 | 86.05% |
| Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 77.84 | 2.25B | 0.66% | 32.75 | 23.61% |
| Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 65.68 | 1.75B | 1.23% | n/a | 8.60% |
| Alpa Laboratories Limited | ALPA | Drug Manufacturers-Specialty & Generic | 68.92 | 1.46B | 0.12% | 13.54 | 3.45% |
| Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 65.01 | 1.40B | -0.81% | n/a | -162.25% |
| Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 86.23 | 1.38B | -1.01% | 25.83 | 201.53% |
| Par Drugs And Chemicals Limited | PAR | Drug Manufacturers-Specialty & Generic | 89.89 | 1.12B | 3.67% | 19.90 | 0.00% |
| Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 35.29 | 589.40M | 0.34% | 181.38 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Madhav Copper Limited | MCL | Copper | 59.6 | 1.64B | -0.28% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 86.92 | 1.26B | -0.36% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 70.46 | 785.54M | -2.29% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 24.6 | 427.05M | -3.42% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.24 | 158.63M | 3.43% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 28.30 | 24.85 | Par |
| Ent. to Revenue | 3.88 | 11.40 | Cheaper |
| PE Ratio | 82.74 | 51.36 | Expensive |
| Price to Book | 3.26 | 6.83 | Cheaper |
| Dividend Yield | 0.19 | 0.52 | Poor |
| Std. Deviation (3M) | 47.20 | 42.17 | Par |
| Debt to Equity | 0.15 | 0.35 | Cheaper |
| Debt to Assets | 0.10 | 0.17 | Cheaper |
| Market Cap | 3.03B | 290.82B | Emerging |